No services found
No Products found
100ug, 1MG
ProteoGenix
Primary Antibodies, Therapeutic Antibodies
Monoclonal Antibody
Mammalian cells
Elisa, WB
Urelumab is a human antibody targeting CD137. Urelumab has been investigated for the treatment of Leukemia, Multiple Myeloma, Malignant Tumors, Cancer – Solid Tumors and B-Cell Non-Hodgkin’s Lymphoma.
Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb, on SDS-PAGE under reducing and non-reducing conditions. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Immobilized CD137 Recombinant Protein (cat. No.PX-P4107) at 0.5µg/mL (100µL/well) can bind to Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb (cat. No.PX-TA1265) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450
Reviews
There are no reviews yet.
Your email address will not be published. Required fields are marked *
In which application did you use the antibody? * WB ELISA Sandwich ELISA IF IHC IP FC other
Did it work in your application? * Yes No
Your review *
Name *
Email *
Save my name, email, and website in this browser for the next time I comment.
Related products
Send us a message from the form below
First name
Last name
Email address
Lab / Company
Phone number
Message
send
Your cart is currently empty.